AmiugOusrt;T908!"m*}        American  Medical  Association.  395 
simplicity  in  prescribing,  and  included  a  strong  plea  for  discouraging 
the  use  of  all  fixed  formulas  in  the  treatment  of  disease. 
Prof.  Jos.  P.  Remington,  as  Chairman  of  the  Delegation  from  the 
American  Pharmaceutical  Association,  presented  the  greetings  of 
that  organization  and  briefly  outlined  the  present  situation  of  phar- 
macy in  its  relation  to  medicine. 
Prof.  C.  S.  N.  Hallberg,  the  Secretary  of  the  Section,  presented 
an  unusually  interesting  report,  in  which  he  reviewed  the  present- 
day  status  of  so-called  "  patent  medicines."  He  also  directed  atten- 
tion to  the  all  too  flagrant  abuses  of  the  letter  as  well  as  the  spirit 
of  the  laws  regulating  second-class  postal  rates,  and  advised  that  the 
post  office  authorities  be  requested  to  rescind  these  privileges  in  the 
case  of  publications  carrying  fraudulent  medical  advertisements. 
The  liberal  discussion  that  was  evoked  by  the  several  communi- 
cations bearing  on  the  Pharmacopoeia  and  the  National  Formulary 
was  particularly  interesting  in  that  it  evidenced  a  marked  reawak- 
ening on  the  part  of  physicians  in  matters  relating  to  our  National 
standards. 
A  paper  read  by  Dr.  O.  T.  Osborne  on  (i  The  Sufficiency  of  the 
Official  Drugs  and  Preparations  "  precipitated  an  unusually  lively 
discussion  that  evidenced  the  need  for  differentiating,  somewhat 
sharply,  between  pharmacists  and  drug  sellers. 
The  concluding  meeting  of  the  Section  was  devoted  entirely  to  a 
Symposium  on  the  Pharmacopoeia  and  the  National  Formulary. 
Dr.  Torald  Sollman,  Dr.  James  M.  Anders,  Dr.  H.  W.  Wiley,  Dr. 
C.  F.  Wahrer  and  Prof.  H.  Vin  Arny  had  prepared  papers,  and 
these  were  read  either  by  the  authors  themselves  or  their  repre- 
sentatives. 
The  discussion  on  these  several  papers  was  opened  by  Prof.  Joseph 
P.  Remington,  the  Chairman  of  the  Committee  on  Revision  of  the 
U.S. P.,  and  was  continued  by  a  number  of  the  members  present. 
Dr.  Reid  Hunt,  as  Chairman  of  the  Committee  of  the  American 
Medical  Association,  on  the  Revision  of  the  Pharmacopoeia, 
announced  that  this  committee  had  been  organized  and  that  the 
members  would  be  in  position  to  proceed  with  routine  work  in  the 
very  near  future. 
Throughout  the  discussion  it  was  evident  that  physicians  were 
intensely  interested  in  matters  relating  to  the  Pharmacopoeia,  and  that 
in  the  near  future  they  will  be  much  better  able  to  judge  of  phar- 
maceutical products  than  ever  before. 
